The U.S. District Judge conducted virtual online interviews of more than 60 attorneys to choose 24 plaintiffs' lawyers for the proceedings of Zantac lawsuits.
According to research, the use of Zantac has side effects on the users like exposure to cancer. Sanofi the manufacturing company of Zantac currently faces 200 product liability lawsuits with similar allegations that the drug has developed breast cancer, testicular cancer, kidney cancer, bladder cancer, stomach cancer, or other injuries to the plaintiffs.
It is estimated that more thousand claims of the Zantac lawsuits will be filed in the coming year against the company. The lawsuits claim that ranitidine, an active ingredient in Zantac, produces high levels of the known human carcinogen Nitrosodimethylamine (NDMA), and the drug makers are aware of it.
In February 2020, all the Zantac lawsuits were centralized before the U.S. District Judge Robin L. Rosenberg in the Southern District of Florida to avoid duplicative discoveries and multiple individual trials.
Due to the ongoing COVID-19 pandemic, Judge Rosenberg was forced to conduct virtual interviews of 63 lawyers for the proceedings of the trials in the Zantac MDL. According to a pretrial order issued on May 8, Judge Rosenberg identified a group of 24 attorneys from law firms nationwide, which included four co-lead counsels, one liaison counsel, 15 members of a Plaintiffs’ Steering Committee (PSC), and five lawyers to serve on a leadership development committee.
